# Susan E. Bates

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/susan-e-bates/

## Facts

| Field | Value |
| --- | --- |
| Citations | 52,187 |
| Field | Drug Transport and Resistance Mechanisms |
| h-index | 111 |
| i10-index | 369 |
| Last Known Institution | The Nature Conservancy |
| OpenAlex ID | https://openalex.org/A5013592290 |
| ORCID iD | https://orcid.org/0000-0001-6708-0330 |
| Works | 955 |

## Researcher papers

- [Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-in-combination-with-gemcitabine-and-cisplatin-compared-with/)
- [Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors](https://scholariq.org/papers/phase-i-study-of-atr-inhibitor-m6620-in-combination-with-topotecan-in-patients/)

## Researcher topics

- [Drug Transport and Resistance Mechanisms](https://scholariq.org/topics/drug-transport-and-resistance-mechanisms/)
- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [The Nature Conservancy](https://scholariq.org/institutions/the-nature-conservancy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.